Purple Book

Description

The “Purple Book” originally was available as two separate lists of FDA-licensed biological products regulated by the Center for Drug Evaluation and Research (CDER) and FDA-licensed biological products regulated by the Center for Biologics Evaluation and Research (CBER).

The FDA has transitioned the Purple Book to a searchable, online database that contains information about  biological products, including biosimilar and interchangeable biological products, licensed (approved) by the FDA under the Public Health Service (PHS) Act.

Currently, the searchable database contains information about all FDA-licensed biological products regulated by CDER, including licensed biosimilar and interchangeable products, and their reference products, and FDA-licensed allergenic, cellular and gene therapy, hematologic, and vaccine products regulated by CBER.

• More Information about the Purple Book

Source Links

Download

API

Update Frequency

Licensing

Table Info

On this page

• Purple Book
• Description
• Source Links
• Download
• API
• Update Frequency
• Licensing
• Table Info